U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07555938) titled 'Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma' on April 22.
Brief Summary: The purpose of this study is to assess the efficacy and safety of cevostamab in combination with pomalidomide and dexamethasone (CevosPd) versus standard of care (SOC) in participants with multiple myeloma (MM) who have received one to three prior lines of therapy and have been exposed to an anti-CD38 monoclonal antibody (mAb) and lenalidomide.
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Multiple Myeloma
Intervention:
DRUG: Cevostamab
Pa...